Evotec SE (EVOTF)
3.890
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Evotec Net Income (Quarterly) : -54.24M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -54.24M |
| March 31, 2026 | -142.66M |
| December 31, 2025 | 17.02M |
| September 30, 2025 | -50.35M |
| June 30, 2025 | -49.28M |
| March 31, 2025 | -33.23M |
| December 31, 2024 | -43.56M |
| September 30, 2024 | -43.54M |
| June 30, 2024 | -102.20M |
| March 31, 2024 | -22.44M |
| December 31, 2023 | -17.35M |
| September 30, 2023 | -42.38M |
| June 30, 2023 | -16.25M |
| March 31, 2023 | -14.91M |
| December 31, 2022 | -27.75M |
| September 30, 2022 | -47.59M |
| June 30, 2022 | -29.73M |
| March 31, 2022 | -82.17M |
| December 31, 2021 | -35.98M |
| September 30, 2021 | 158.27M |
| June 30, 2021 | 72.36M |
| March 31, 2021 | 63.48M |
| December 31, 2020 | 0.4805M |
| September 30, 2020 | -1.648M |
| June 30, 2020 | -10.81M |
| Date | Value |
|---|---|
| March 31, 2020 | 18.81M |
| December 31, 2019 | 8.325M |
| September 30, 2019 | 21.18M |
| June 30, 2019 | -2.683M |
| March 31, 2019 | 14.82M |
| December 31, 2018 | 36.26M |
| September 30, 2018 | 40.02M |
| June 30, 2018 | 17.02M |
| March 31, 2018 | 4.246M |
| December 31, 2017 | 12.37M |
| September 30, 2017 | 2.778M |
| June 30, 2017 | 3.549M |
| March 31, 2017 | 7.563M |
| December 31, 2016 | 16.66M |
| September 30, 2016 | 9.669M |
| June 30, 2016 | 4.396M |
| March 31, 2016 | -1.292M |
| December 31, 2015 | 6.400M |
| September 30, 2015 | -3.208M |
| June 30, 2015 | 16.18M |
| March 31, 2015 | -1.205M |
| December 31, 2014 | 1.270M |
| September 30, 2014 | -4.727M |
| June 30, 2014 | -0.5787M |
| March 31, 2014 | -5.489M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Sartorius AG | 107.78M |
| SCHOTT Pharma AG & Co. KGaA | 45.32M |
| Agilent Technologies, Inc. | 362.00M |
| Bio-Rad Laboratories, Inc. | 371.40M |
| Bruker Corp. | -50.90M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 166.82M |
| Total Expenses (Quarterly) | 221.06M |
| EPS Diluted (Quarterly) | -0.3051 |
| Enterprise Value | 702.67M |
| Gross Profit Margin (Quarterly) | -1.10% |
| Profit Margin (Quarterly) | -32.51% |
| Earnings Yield | -33.31% |
| Normalized Earnings Yield | -24.59 |